{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-007399","form_type":"8-K","ticker":"GAMG","cik":"0000055234","company_name":"Global Asset Management Group, Inc.","filed_at":"2023-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.724688+00:00","generated_at":"2026-06-10T04:21:08.304440+00:00","sec_items":["2.01","5.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kenilworth Systems acquires 60% of Regenecell in share exchange; Swank joins board","bullets":["KENS issued 2M shares to Steven Swank for 600k shares of Regenecell, gaining 60% control.","Regenecell net loss $45,872 on $31k revenue for June-Sept 2023; auditor notes going concern doubt.","Pro forma combined net loss $26,724; KENS shareholders' deficit ~$72k post-acquisition.","Steven Swank, 83, appointed Director and Secretary effective Sept 30, 2023.","Regenecell provides medical travel consulting; Swank retains 40% minority interest."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-007399","json":"https://secwatch.observer/filing/0001477932-23-007399.json","markdown":"https://secwatch.observer/filing/0001477932-23-007399.md","text":"https://secwatch.observer/filing/0001477932-23-007399.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55234/000147793223007399/0001477932-23-007399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55234/000147793223007399/kens_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T04:21:08.304440+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a43019f3b6","claim":"Steven Swank was appointed as Director and Secretary at Global Asset Management Group, Inc..","evidence_excerpt":"On September 30, 2023, Steven Swank was appointed as a Director and Secretary of the Company following the acquisition by the Company of a 60% controlling interest in Regenecell, Inc., a Company of which Mr. Swank was the President and Founder.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/55234/000147793223007399/0001477932-23-007399-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Secretary"}],"fact_type":"executive_change"},{"claim_id":"73b5d2fc60b4da68d7007b7b470d9d0997eac5cb","claim":"Global Asset Management Group, Inc. completed an acquisition involving Regenecell, Inc. (closed 2023-09-30).","evidence_excerpt":"On September 30, 2023, the Company completed a Share Exchange in which it acquired a 60% controlling equity interest in Regenecell, Inc., a Florida corporation which has been newly-formed and is engaged in the business of medical travel consulting and referral services.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/55234/000147793223007399/0001477932-23-007399-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Regenecell, Inc."},{"label":"Closing","value":"2023-09-30"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}